Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
- PMID: 32488813
- PMCID: PMC7645575
- DOI: 10.1007/s40265-020-01333-9
Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
Abstract
The affiliation of the corresponding author Silvio Danese, which currently reads.
Erratum for
-
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases.Drugs. 2020 Feb;80(2):99-113. doi: 10.1007/s40265-020-01256-5. Drugs. 2020. PMID: 32002851 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources